These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 15322019)
1. Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis. Windbichler M; Echtenacher B; Hehlgans T; Jensenius JC; Schwaeble W; Männel DN Infect Immun; 2004 Sep; 72(9):5247-52. PubMed ID: 15322019 [TBL] [Abstract][Full Text] [Related]
2. Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis. Celik I; Stover C; Botto M; Thiel S; Tzima S; Künkel D; Walport M; Lorenz W; Schwaeble W Infect Immun; 2001 Dec; 69(12):7304-9. PubMed ID: 11705901 [TBL] [Abstract][Full Text] [Related]
3. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans. Held K; Thiel S; Loos M; Petry F Mol Immunol; 2008 Sep; 45(15):3934-41. PubMed ID: 18672286 [TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Roos A; Garred P; Wildenberg ME; Lynch NJ; Munoz JR; Zuiverloon TC; Bouwman LH; Schlagwein N; Fallaux van den Houten FC; Faber-Krol MC; Madsen HO; Schwaeble WJ; Matsushita M; Fujita T; Daha MR Eur J Immunol; 2004 Sep; 34(9):2589-98. PubMed ID: 15307191 [TBL] [Abstract][Full Text] [Related]
5. Activation of the alternative complement pathway by mannose-binding lectin via a C2-bypass pathway. Tateishi K; Matsushita M Microbiol Immunol; 2011 Nov; 55(11):817-21. PubMed ID: 21831201 [TBL] [Abstract][Full Text] [Related]
6. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205 [TBL] [Abstract][Full Text] [Related]
7. Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions. Harboe M; Garred P; Borgen MS; Stahl GL; Roos A; Mollnes TE Clin Exp Immunol; 2006 Jun; 144(3):512-20. PubMed ID: 16734621 [TBL] [Abstract][Full Text] [Related]
8. STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis. Godshall CJ; Lentsch AB; Peyton JC; Scott MJ; Cheadle WG Clin Diagn Lab Immunol; 2001 Nov; 8(6):1044-8. PubMed ID: 11687437 [TBL] [Abstract][Full Text] [Related]
9. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation. Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537 [TBL] [Abstract][Full Text] [Related]
10. Binding and activation of human and mouse complement by Cryptosporidium parvum (Apicomplexa) and susceptibility of C1q- and MBL-deficient mice to infection. Petry F; Jakobi V; Wagner S; Tessema TS; Thiel S; Loos M Mol Immunol; 2008 Jul; 45(12):3392-400. PubMed ID: 18501966 [TBL] [Abstract][Full Text] [Related]
11. Investigations on the involvement of the lectin pathway of complement activation in anaphylaxis. Windbichler M; Echtenacher B; Takahashi K; Ezekowitz RA; Schwaeble WJ; Jenseniuis JC; Männel DN Int Arch Allergy Immunol; 2006; 141(1):11-23. PubMed ID: 16804320 [TBL] [Abstract][Full Text] [Related]
12. A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin. Inoshita H; Matsushita M; Koide S; Kusaba G; Ishii M; Onda K; Gi MJ; Nakata M; Ohsawa I; Horikoshi S; Ohi H; Tomino Y J Immunol Methods; 2009 Sep; 349(1-2):9-17. PubMed ID: 19699205 [TBL] [Abstract][Full Text] [Related]
13. The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification. Harboe M; Garred P; Karlstrøm E; Lindstad JK; Stahl GL; Mollnes TE Mol Immunol; 2009 Dec; 47(2-3):373-80. PubMed ID: 19800125 [TBL] [Abstract][Full Text] [Related]